menu search

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsentan in FSGS 11 total abstracts accepted for presentation highlight Travere’s leadership and commitment in the field of rare kidney disease SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: […] The post Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 appeared first on... Read More
Posted: Oct 13 2023, 20:30
Author Name: forextv
Views: 091976

Search within

Pages Search Results: